These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 8483303)

  • 1. Antisecretory and antiulcer effects of ebselen, a seleno-organic compound, in rats.
    Tabuchi Y; Kurebayashi Y
    Jpn J Pharmacol; 1993 Mar; 61(3):255-7. PubMed ID: 8483303
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protective effect of ebselen, a seleno-organic compound, against the progression of acute gastric mucosal lesions induced by compound 48/80, a mast cell degranulator, in rats.
    Ohta Y; Kobayashi T; Inui K; Yoshino J; Nakazawa S
    Jpn J Pharmacol; 2002 Dec; 90(4):295-303. PubMed ID: 12501005
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanism of the inhibition of hog gastric H+,K(+)-ATPase by the seleno-organic compound ebselen.
    Tabuchi Y; Ogasawara T; Furuhama K
    Arzneimittelforschung; 1994 Jan; 44(1):51-4. PubMed ID: 8135879
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential effect of ebselen on compound 48/80- and anti-IgE-induced histamine release from rat peritoneal mast cells.
    Tchoumkeu-Nzouessa GC; Rebel G
    Biochem Pharmacol; 1998 Dec; 56(11):1525-8. PubMed ID: 9827587
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interaction of the anti-inflammatory seleno-organic compound ebselen with acid secretion in isolated parietal cells and gastric H+/K(+)-ATPase.
    Beil W; Staar U; Sewing KF
    Biochem Pharmacol; 1990 Nov; 40(9):1997-2003. PubMed ID: 2173597
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ebselen, a seleno-organic compound, protects against ethanol-induced murine gastric mucosal injury in both in vivo and in vitro systems.
    Tabuchi Y; Sugiyama N; Horiuchi T; Furusawa M; Furuhama K
    Eur J Pharmacol; 1995 Jan; 272(2-3):195-201. PubMed ID: 7713163
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acute antiinflammatory and gastric effects of the seleno-organic compound ebselen.
    Leyck S; Parnham MJ
    Agents Actions; 1990 Jun; 30(3-4):426-31. PubMed ID: 2117337
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effect of seleno-organic compounds on leukotriene B4 biosynthesis].
    Liu DP; Cheng GF; Bai JY; Guo ZR; Zhu XY
    Yao Xue Xue Bao; 1993; 28(6):472-6. PubMed ID: 8249607
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of DS-4574, a novel peptidoleukotriene antagonist with mast cell stabilizing action, on acute gastric lesions and gastric secretion in rats.
    Tabuchi Y; Kurebayashi Y
    Jpn J Pharmacol; 1992 Dec; 60(4):335-40. PubMed ID: 1287268
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of ebselen on polymorphonuclear leukocyte migration to joints in rats with adjuvant arthritis.
    Gao JX; Issekutz AC
    Int J Immunopharmacol; 1993 Oct; 15(7):793-802. PubMed ID: 8262693
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ebselen has dehydroascorbate reductase and thioltransferase-like activities.
    Jung CH; Washburn MP; Wells WW
    Biochem Biophys Res Commun; 2002 Mar; 291(3):550-3. PubMed ID: 11855823
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Susceptibility of mice to bacterial and fungal infections after intragastric administration of ebselen.
    Nozawa R; Arai M; Kuruto R; Motohashi T; Masayasu H
    J Pharm Pharmacol; 1996 Jan; 48(1):64-7. PubMed ID: 8722498
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gastric antisecretory and antiulcer activity of oxytocin in rats and guinea pigs.
    Asad M; Shewade DG; Koumaravelou K; Abraham BK; Vasu S; Ramaswamy S
    Life Sci; 2001 Nov; 70(1):17-24. PubMed ID: 11764003
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effects of 3-hydroxymethyl-2-methylimidazo [2, 1-b] benzothiazole (NIK-228) on gastric acid secretion and various experimental peptic ulcers in rats].
    Hoshino R; Kagoshima M; Shimada H
    Nihon Yakurigaku Zasshi; 1991 May; 97(5):287-96. PubMed ID: 1879806
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gastric cytoprotection by ebselen against the injury induced by necrotizing agents in rats.
    Kurebayashi Y; Tabuchi Y; Akasaki M
    Arzneimittelforschung; 1989 Feb; 39(2):250-3. PubMed ID: 2730695
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antisecretory and antiulcer effect of T-330, a novel reversible proton pump inhibitor, in rats.
    Kinoshita M; Saito N; Tamaki H
    Eur J Pharmacol; 1997 Mar; 321(3):325-32. PubMed ID: 9085044
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gastric cytoprotective, antisecretory and antiulcer activities of (E)-4-oxo-4-(3,4,5-trimethoxyphenyl)-2-butenoic acid (RU 38086).
    Barzaghi F; Cesana R; Delevallée F; Fournex R; Nencioni A; Vincent JC; Deraedt R
    Arzneimittelforschung; 1985; 35(9):1412-6. PubMed ID: 4084342
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ebselen as protection against ethanol-induced toxicity in rat stomach.
    Unlüçerçi YM; Bulut R; Bekpinar S; Kuntsal L
    J Trace Elem Med Biol; 1999 Nov; 13(3):170-5. PubMed ID: 10612080
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preventive effect of ebselen on acute gastric mucosal lesion development in rats treated with compound 48/80.
    Kobayashi T; Ohta Y; Yoshino J
    Eur J Pharmacol; 2001 Mar; 414(2-3):271-9. PubMed ID: 11239928
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of KW-5805, a new antiulcer agent, on experimental gastric and duodenal ulcers, gastric mucosal lesions by necrotizing agents and gastric acid secretion.
    Kosaka N; Tanaka H; Tomaru A; Ishii A; Shuto K
    Jpn J Pharmacol; 1994 Aug; 65(4):305-12. PubMed ID: 7990267
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.